p16INK4a should be used as surrogate marker for HPV-driven carcinogenesis in vulvar cancer only with caution, as more and more evidence arises that there seem to be other HPV-independent mechanisms in vulvar cancer leading to p16INK4a overexpression. The gene discussed is CDKN2A; the disease is vulva cancer.